Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation
Kanorskiĭ, S.G.; Zingilevskiĭ, K.B.
Kardiologiia 42(8): 44-45
2002
ISSN/ISBN: 0022-9040 PMID: 12494094 Document Number: 547086
Document emailed within 1 workday
Related Documents
Chauvin, M.; Koenig, A.; Brechenmacher, C. 1991: Internal electroshock in the treatment of chronic atrial fibrillation resistant to external cardioversion. Initial results apropos of 21 patients Annales de Cardiologie et d'Angeiologie 40(1): 47-50Michelucci, A.; Lazzeri, C.; Padeletti, L.; Bagliani, G.; Colella, A.; Sabini, A.; Zipoli, R.; Costoli, A.; Pieragnoli, P.; Gensini, G.F.; Franchi, F. 2001: Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: preliminary data Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(6): 435-440
Fradi, I.; Mokaddem, A.; Selmi, K.él.; Boujnah, M.R. 2006: Chronic atrial fibrillation in adults: direct current cardioversion or medical cardioversion La Tunisie Medicale 84(12): 772-776
Santini, M.; Pandozi, C.; Altamura, G.; Toscano, S.; Castro, A.; Villani, M.; Ammirati, F.; Gentilucci, G.; Scianaro, M.C.; Magris, B. 1998: The efficacy of high- and low-energy intracavitary cardioversion in chronic atrial fibrillation refractory to transthoracic cardioversion Giornale Italiano di Cardiologia 28(7): 788-796
Bugán, V.; Renker, B.; Brunclík, P.; Baraniková, D.; Augustín, E. 1994: Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study Vnitrni Lekarstvi 40(4): 219-222
Zheng, Z. 1990: The use of digoxin and diltiazem in controlling ventricular rate in chronic atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 18(1): 8-10
Chauvin, M.; Koenig, A.; Theolade, R.; Brechenmacher, C. 1991: Role of internal cardioversion in the treatment of permanent atrial fibrillation. Early results apropos of 28 cases Archives des Maladies du Coeur et des Vaisseaux 84(3): 377-382
Van Gelder, I.C.; Crijns, H.J.; Tieleman, R.G.; Brügemann, J.; De Kam, P.J.; Gosselink, A.T.; Verheugt, F.W.; Lie, K.I. 1996: Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation Archives of Internal Medicine 156(22): 2585-2592
Fetsch, T.; Burschel, G.; Breithardt, G.; Engberding, R.; Koch, H.P.; Lukl, J.; Trappe, H.J.; Treese, N. 1999: Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study Zeitschrift für Kardiologie 88(3): 195-207
Stratton, J.R. 2001: Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation New England Journal of Medicine 345(11): 838-839
Anderson, K.P. 2001: Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation New England Journal of Medicine 345(11): 837; Author Reply 838-839
Behera, M.; Mohapatra, N.K. 1986: Stable sinus impulse appearance time (SSIAT)--a predictor of long-term results of DC cardioversion in atrial fibrillation Indian Heart Journal 38(1): 38-41
Gurciková, M.; Kaluzay, J.; Remisová, S.; Jurkovicová, O.; Pontuch, P. 2008: Late recurrences of atrial fibrillation in patients after direct-current cardioversion Vnitrni Lekarstvi 54(6): 604-608
Bartkowiak, R.ła.; Wozakowska-Kapłon, B.; Janiszewska, G. 2010: Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion Kardiologia Polska 68(1): 48-54
2006: Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients MMW Fortschritte der Medizin 148(23): 58-59
Kubac, G.; Malowany, L. 1992: Functional capacity of patients with atrial fibrillation and controlled heart rate before and after cardioversion Canadian Journal of Cardiology 8(9): 941-946
Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626
Tarquinii, M.; Lolli, C.; Foscoli, M.; Giofrè, R.; Labriola, E.; Toschi, G.P. 1993: Prevention of paroxysmal atrial fibrillation with propafenone after withdrawal of amiodarone because of side effects La Clinica Terapeutica 142(4): 341-346
Paventi, S.; Parafati, M.A.; Pellegrino, C.A.; Bevilacqua, U.; Paggi, A. 1999: Atrial stunning and pharmacologic cardioversion in idiopathic atrial fibrillation of recent onset Minerva Cardioangiologica 47(7-8): 239-244
Davy, J.M.; Raczka, F.; Beck, L.; Piot, C. 2003: Mechanisms of action of antiarrhythmics in cardioversion of atrial fibrillation and atrial flutter Archives des Maladies du Coeur et des Vaisseaux 96(Special Issue 4): 20-29